- Home
- Publications
- Publication Search
- Publication Details
Title
An Overview of Vasculogenic Mimicry in Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-02-27
DOI
10.3389/fonc.2020.00220
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231
- (2019) Meng-Ran Xu et al. Biomed Research International
- Breast Cancer Treatment
- (2019) Adrienne G. Waks et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Checkpoint Blockade Strategies in the Treatment of Breast Cancer: Where We Are and Where We Are Heading
- (2019) Jeremy Force et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry in vitro
- (2019) Julie-Ann Hulin et al. BIOMEDICINE & PHARMACOTHERAPY
- The Role of CDK4/6 Inhibitors in Breast Cancer
- (2019) Conleth G. Murphy CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Alpelisib: First Global Approval
- (2019) Anthony Markham DRUGS
- Evidence to date: talazoparib in the treatment of breast cancer
- (2019) Pedro Exman et al. OncoTargets and Therapy
- Breast cancer
- (2019) Nadia Harbeck et al. Nature Reviews Disease Primers
- Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells
- (2018) Yarely M. Salinas-Vera et al. CANCER LETTERS
- Emerging roles of microRNAs in cancer
- (2018) Ivan Vannini et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- miR‑141 inhibits glioma vasculogenic mimicry by controlling EphA2 expression
- (2018) Guoxiong Li et al. Molecular Medicine Reports
- Knockdown of ZEB1 suppressed the formation of vasculogenic mimicry and epithelial-mesenchymal transition in the human breast cancer cell line MDA-MB-231
- (2018) Weili Liang et al. Molecular Medicine Reports
- Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis
- (2018) Wei Tao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer
- (2018) Peng Xing et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Epithelial-to-mesenchymal transition in cancer: complexity and opportunities
- (2018) Yun Zhang et al. Frontiers of Medicine
- Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel
- (2018) Yuki Izawa et al. ACTA HISTOCHEMICA ET CYTOCHEMICA
- Atezolizumab for the treatment of triple-negative breast cancer
- (2018) Anne-Sophie Heimes et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Recent advances in breast cancer research impacting clinical diagnostic practice
- (2018) Amy E McCart Reed et al. JOURNAL OF PATHOLOGY
- Hypoxia-inducible factor 1-alpha expression correlates with response to neoadjuvant chemotherapy in women with breast cancer
- (2018) Caiyun Nie et al. MEDICINE
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The expression of VE-cadherin in breast cancer cells modulates cell dynamics as a function of tumor differentiation and promotes tumor–endothelial cell interactions
- (2017) Maryam Rezaei et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Expression and significance of Twist, estrogen receptor, and E-cadherin in human breast cancer cells and tissues
- (2017) Tao He et al. Journal of Cancer Research and Therapeutics
- Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin
- (2017) Daniel Delgado-Bellido et al. Molecular Cancer
- Osteopontin and vasculogenic mimicry formation are associated with response to neoadjuvant chemotherapy in advanced breast cancer
- (2017) Ming Gu et al. OncoTargets and Therapy
- MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1
- (2017) Julie-Ann Hulin et al. Scientific Reports
- Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis
- (2017) Weiqiang Qiao et al. PLoS One
- HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells
- (2017) Na-Na Tang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Cancer Stem Cells: Basic Concepts and Therapeutic Implications
- (2016) Dany Nassar et al. Annual Review of Pathology-Mechanisms of Disease
- The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment
- (2016) Shuixian Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Tumour angiogenesis-Origin of blood vessels
- (2016) S. Krishna Priya et al. INTERNATIONAL JOURNAL OF CANCER
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells
- (2016) Baocun Sun et al. OncoTargets and Therapy
- Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways
- (2016) Kunxin Luo Cold Spring Harbor Perspectives in Biology
- Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor
- (2016) DOM-GENE TU et al. Oncology Letters
- Nodal signaling promotes vasculogenic mimicry formation in breast cancer via the Smad2/3 pathway
- (2016) Wenchen Gong et al. Oncotarget
- Significance of twist and iNOS expression in human breast carcinoma
- (2015) Santhalakshmi Ranganathan et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A model of breast cancer heterogeneity reveals vascular mimicry as a driver of metastasis
- (2015) Elvin Wagenblast et al. NATURE
- Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation
- (2015) Yong-Qu Zhang et al. PLoS One
- Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer
- (2015) Fan Zeng et al. Oncotarget
- Changing Treatment Paradigms in Metastatic Breast Cancer
- (2015) Cesar A. Santa-Maria et al. JAMA Oncology
- Epidermal growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry activity of breast cancer stem/progenitor cells
- (2014) Che-Hsin Lee et al. BIOCHIMIE
- Liposomes, modified with PTDHIV-1 peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer
- (2014) Rui-Jun Ju et al. BIOMATERIALS
- OCT4 Expression and Vasculogenic Mimicry Formation Positively Correlate with Poor Prognosis in Human Breast Cancer
- (2014) Tieju Liu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer
- (2014) Danfang Zhang et al. Molecular Cancer
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition
- (2013) Hans-Peter Sinn et al. Breast Care
- A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review)
- (2013) YUN-LONG FAN et al. Oncology Letters
- HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma
- (2012) Tieju Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer
- (2012) T J Liu et al. ONCOGENE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Eph/Ephrin Profiling in Human Breast Cancer Reveals Significant Associations between Expression Level and Clinical Outcome
- (2011) Dana M. Brantley-Sieders et al. PLoS One
- Signalling pathways in vasculogenic mimicry
- (2010) Yvette W.J. Paulis et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Bmi1 is essential in Twist1-induced epithelial–mesenchymal transition
- (2010) Muh-Hwa Yang et al. NATURE CELL BIOLOGY
- Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
- (2009) E. Charafe-Jauffret et al. CLINICAL CANCER RESEARCH
- Spheroid-forming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsa-miR-299-5p regulated de novo expression of osteopontin
- (2009) Lalita A. Shevde et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Vascular Endothelial Cadherin Promotes Breast Cancer Progression via Transforming Growth Factor Signaling
- (2008) M. Labelle et al. CANCER RESEARCH
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search